Stocks / Biotech
BCRXBiotech
BioCryst Pharmaceuticals Inc
$8.671d +3.0%5d +3.3%settled close · 2026-09-17
Mkt cap $2.4B (3/25)β 0.4352w $6.24–11.10Shares 250.8MInd. Biological Products, (No Diagnostic Substances)Nasdaq since 1994Emp. 435HQ Durham, NCbiocryst.com
Who’s talkingIdea Scout · free
Who’s talking about BCRX
No tracked investor commentary on BCRX yet — the corpus grows weekly.
Idea Scout tracks who’s
talking across television, podcasts, and interviews — every stance
dated to the appearance it came from.
Sign up free →
Earnings
Next report: 2 Nov 2026 before the open
Confirmed date · consensus EPS 0.08. Reactions below are the next settled session over the prior close.
The options tapeThe Brief · paid
Notable options days
Sessions in the last 120 where BCRX’s settled options volume ran ≥ 2× its trailing 20-session baseline, or delta-dollar flow ran ≥ 2.5× — 17 of 120 sessions qualified.
The qualifying dates are the free record. Close, flow, call/LEAPS mix and the 20-session outcome — for every session below — are Brief subscriber content.
| Date | Close | RVOL | Δ$ flow ($M) | Call % | LEAPS % | +20 sess. |
|---|---|---|---|---|---|---|
| 2026-08-27 | ||||||
| 2026-08-18 | ||||||
| 2026-08-13 | ||||||
| 2026-08-12 | ||||||
| 2026-08-11 | ||||||
| 2026-06-25 | ||||||
| 2026-06-24 | ||||||
| 2026-06-23 | ||||||
| 2026-05-27 | ||||||
| 2026-05-14 | ||||||
| 2026-05-13 | ||||||
| 2026-05-06 | ||||||
| 2026-03-20 | ||||||
| 2026-03-17 | ||||||
| 2026-03-16 | ||||||
| 2026-03-11 | ||||||
| 2026-03-10 |
+20 sess. = raw price change over the following 20
sessions — not market-adjusted; the tape tells you where to look,
not what happens next.
Today’s tape on
BCRX is in this morning’s Brief.
Get The Brief — $20/mo →